Literature DB >> 17519731

Long-lasting and permanent fillers: biomaterial influence over host tissue response.

Pierre J Nicolau1.   

Abstract

BACKGROUND: The purpose of this study was to attempt to understand why some injectable fillers produce frequent ill effects and some do not, by reviewing the available agents and analyzing them through the knowledge of biomaterial studies, which show clearly what type of reactions can be expected according to the chemical used.
METHODS: A study of long-lasting and permanent fillers was performed in an attempt to understand the specific reactions induced by each agent. Agents were then compared with manufacturers' allegations and published data on complications.
RESULTS: All the available products have a potential for complications. However, the difference between the normal healing process and true inflammatory granuloma must be established. For a volume effect, the implant, although deep, should induce the smallest inflammatory reaction, to avoid any long-term side effects. Particulate implants with porous or irregular surfaces are potentially more reactive than spherical, smooth-surface particles. Gels and oils have a potential for fragmentation, and each droplet will start a new inflammatory phase. For a superficial treatment, is seems better to use a "passive" filler, which should have no inflammatory reaction. The problem remains for combined indications: volume and smoothing, deep and superficial. After hyaluronic acid injections in areas previously treated with a nonresorbable agent, severe inflammatory granulomas have appeared, and it is not possible to state whether they are attributable to the new product, even a resorbable one, or to reactivation of the sleeping reaction from the previous implant.
CONCLUSION: There is an obvious need for serious, precise, and objective studies on most of the available fillers, which have not been properly scientifically studied on human skin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519731     DOI: 10.1097/01.prs.0000260710.30934.a1

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  Distinct granuloma responses in C57BL/6J and BALB/cByJ mice in response to pristane.

Authors:  Huaiyong Chen; Dongmei Liao; Derek Cain; Ian McLeod; Yoshihiro Ueda; Ziqiang Guan; Christian Raetz; Garnett Kelsoe
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

2.  Genetic regulation of pristane-induced oil granuloma responses.

Authors:  Huaiyong Chen; Dongmei Liao; T Matt Holl; Pilar Snowden; Yoshihiro Ueda; Garnett Kelsoe
Journal:  Int J Exp Pathol       Date:  2010-08-27       Impact factor: 1.925

3.  Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.

Authors:  Elena Tous; Heather M Weber; Myung Han Lee; Kevin J Koomalsingh; Takashi Shuto; Norihiro Kondo; Joseph H Gorman; Daeyeon Lee; Robert C Gorman; Jason A Burdick
Journal:  Acta Biomater       Date:  2012-05-29       Impact factor: 8.947

4.  Mirror, mirror on the wall: hypercalcemia as a consequence of modern cosmetic treatment with liquid silicone.

Authors:  Jurik Schanz; Katharina Flux; Claudia Kircher; Maria Tsioga; Wolfgang Hartschuh; Peter P Nawroth; Gottfried Rudofsky
Journal:  Med Sci Monit       Date:  2012-02

Review 5.  Beware What You Inject: Complications of Injectables-Dermal Fillers.

Authors:  Maya Vedamurthy
Journal:  J Cutan Aesthet Surg       Date:  2018 Apr-Jun

Review 6.  The Aetiopathogenesis of Late Inflammatory Reactions (LIRs) After Soft Tissue Filler Use: A Systematic Review of the Literature.

Authors:  Y Bachour; J A Kadouch; F B Niessen
Journal:  Aesthetic Plast Surg       Date:  2021-04-28       Impact factor: 2.326

7.  ArteFill permanent injectable for soft tissue augmentation: I. Mechanism of action and injection techniques.

Authors:  Gottfried Lemperle; Terry R Knapp; Neil S Sadick; Stefan M Lemperle
Journal:  Aesthetic Plast Surg       Date:  2009-09-29       Impact factor: 2.326

8.  Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial.

Authors:  Marion Michaela Moers-Carpi; Sally Sherwood
Journal:  Dermatol Surg       Date:  2013-01-25       Impact factor: 3.398

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.